These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30277122)

  • 1. Research articleHemolysis in human erythrocytes by Clostridium perfringens epsilon toxin requires activation of P2 receptors.
    Gao J; Xin W; Huang J; Ji B; Gao S; Chen L; Kang L; Yang H; Shen X; Zhao B; Wang J
    Virulence; 2018; 9(1):1601-1614. PubMed ID: 30277122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic Receptor Antagonists Inhibit Hemolysis Induced by
    Guo Z; Yue N; Chen M; Li J; Lv R; Wang J; Liu T; Huang J; Gao S; Li Y; Yuan B; Wang J; Kang L; Ji B; Xin W
    Pathogens; 2024 May; 13(6):. PubMed ID: 38921752
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis.
    Skals M; Jorgensen NR; Leipziger J; Praetorius HA
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):4030-5. PubMed ID: 19225107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2X receptor stimulation amplifies complement-induced haemolysis.
    Hejl JL; Skals M; Leipziger J; Praetorius HA
    Pflugers Arch; 2013 Apr; 465(4):529-41. PubMed ID: 23149487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium perfringens epsilon toxin binds to erythrocyte MAL receptors and triggers phosphatidylserine exposure.
    Geng Z; Huang J; Kang L; Gao S; Yuan Y; Li Y; Wang J; Xin W; Wang J
    J Cell Mol Med; 2020 Jul; 24(13):7341-7352. PubMed ID: 32463157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viability of SH-SY5Y cells is associated with purinergic P2 receptor expression alterations.
    Örçen A; Yilmaz V; Giriş M; Akcan U; Tüzün E; Erten G
    Acta Biol Hung; 2017 Mar; 68(1):22-34. PubMed ID: 28322086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide.
    Gil C; Dorca-Arévalo J; Blasi J
    PLoS One; 2015; 10(10):e0140321. PubMed ID: 26452234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I
    Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonists and antagonists for P2 receptors.
    Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L
    Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of peripheral P2Y1, P2Y6 and P2Y11 receptors in formalin-induced inflammatory pain in rats.
    Barragán-Iglesias P; Mendoza-Garcés L; Pineda-Farias JB; Solano-Olivares V; Rodríguez-Silverio J; Flores-Murrieta FJ; Granados-Soto V; Rocha-González HI
    Pharmacol Biochem Behav; 2015 Jan; 128():23-32. PubMed ID: 25449358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
    Arvidsson I; Ståhl AL; Hedström MM; Kristoffersson AC; Rylander C; Westman JS; Storry JR; Olsson ML; Karpman D
    J Immunol; 2015 Mar; 194(5):2309-18. PubMed ID: 25637016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice.
    Garcia JP; Adams V; Beingesser J; Hughes ML; Poon R; Lyras D; Hill A; McClane BA; Rood JI; Uzal FA
    Infect Immun; 2013 Jul; 81(7):2405-14. PubMed ID: 23630957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known.
    Alves GG; Machado de Ávila RA; Chávez-Olórtegui CD; Lobato FC
    Anaerobe; 2014 Dec; 30():102-7. PubMed ID: 25234332
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kumar S; Behera SK; Gururaj K; Chaurasia A; Murmu S; Prabha R; Angadi UB; Pawaiya RS; Rai A
    J Biomol Struct Dyn; 2024 Mar; 42(5):2257-2269. PubMed ID: 37129165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins as Potential Preventative Treatment of ETX and Multiple Pore-Forming Toxin-Induced Diseases.
    Huang J; Zhao B; Liu T; Kang L; Li J; Guo Z; Chen M; Gao S; Wang J; Li Y; Wang J; Xin W
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into Clostridium perfringens epsilon toxin activation and action on the brain during enterotoxemia.
    Freedman JC; McClane BA; Uzal FA
    Anaerobe; 2016 Oct; 41():27-31. PubMed ID: 27321761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes.
    Inoue K; Hosoi J; Denda M
    J Invest Dermatol; 2007 Feb; 127(2):362-71. PubMed ID: 16946718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.
    Barrett MO; Sesma JI; Ball CB; Jayasekara PS; Jacobson KA; Lazarowski ER; Harden TK
    Mol Pharmacol; 2013 Jul; 84(1):41-9. PubMed ID: 23592514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.